Monoclonal antibody 15A10

Drug Profile

Monoclonal antibody 15A10

Alternative Names: Anti-cocaine monoclonal antibody

Latest Information Update: 21 Jun 2007

Price : $50

At a glance

  • Originator Columbia University
  • Class Monoclonal antibodies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cocaine abuse

Most Recent Events

  • 19 Jun 2007 MedImmune has since been acquired by AstraZeneca
  • 04 Oct 2004 Discontinued - Preclinical for Cocaine abuse in USA (unspecified route)
  • 19 Oct 1999 Preclinical development for Cocaine abuse in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top